These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 28709937)
41. A breath test for malignant mesothelioma using an electronic nose. Chapman EA; Thomas PS; Stone E; Lewis C; Yates DH Eur Respir J; 2012 Aug; 40(2):448-54. PubMed ID: 22183490 [TBL] [Abstract][Full Text] [Related]
42. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease. Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711 [TBL] [Abstract][Full Text] [Related]
43. Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods. V A B; Subramoniam M; Mathew L Clin Chim Acta; 2021 Dec; 523():231-238. PubMed ID: 34627826 [TBL] [Abstract][Full Text] [Related]
44. BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†. Rocco R; Incalzi RA; Pennazza G; Santonico M; Pedone C; Bartoli IR; Vernile C; Mangiameli G; La Rocca A; De Luca G; Rocco G; Crucitti P Eur J Cardiothorac Surg; 2016 Apr; 49(4):1112-7; discussion 1117. PubMed ID: 26385981 [TBL] [Abstract][Full Text] [Related]
45. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
46. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer]. Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547 [TBL] [Abstract][Full Text] [Related]
47. Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation. Fujita Y; Suda K; Kimura H; Matsumoto K; Arao T; Nagai T; Saijo N; Yatabe Y; Mitsudomi T; Nishio K J Thorac Oncol; 2012 Nov; 7(11):1640-4. PubMed ID: 22899358 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors. Lin CC; Hsu HH; Sun CT; Shih JY; Lin ZZ; Yu CJ; Chen GG; Hsin MK; Lam KC; Leung L; Yang CH; Mok T J Thorac Oncol; 2010 Sep; 5(9):1424-9. PubMed ID: 20631634 [TBL] [Abstract][Full Text] [Related]
50. Detection of lung cancer with electronic nose using a novel ensemble learning framework. Liu L; Li W; He Z; Chen W; Liu H; Chen K; Pi X J Breath Res; 2021 Mar; 15(2):. PubMed ID: 33578407 [TBL] [Abstract][Full Text] [Related]
51. Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study. De Vincentis A; Pennazza G; Santonico M; Vespasiani-Gentilucci U; Galati G; Gallo P; Vernile C; Pedone C; Antonelli Incalzi R; Picardi A Sci Rep; 2016 May; 6():25337. PubMed ID: 27145718 [TBL] [Abstract][Full Text] [Related]
52. Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. Li Y; Xu H; Su S; Ye J; Chen J; Jin X; Lin Q; Zhang D; Ye C; Chen C PLoS One; 2017; 12(8):e0183331. PubMed ID: 28829813 [TBL] [Abstract][Full Text] [Related]
53. Training and Validating a Portable Electronic Nose for Lung Cancer Screening. van de Goor R; van Hooren M; Dingemans AM; Kremer B; Kross K J Thorac Oncol; 2018 May; 13(5):676-681. PubMed ID: 29425703 [TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor mutations in 510 Finnish non--small-cell lung cancer patients. Mäki-Nevala S; Rönty M; Morel M; Gomez M; Dawson Z; Sarhadi VK; Telaranta-Keerie A; Knuuttila A; Knuutila S J Thorac Oncol; 2014 Jun; 9(6):886-91. PubMed ID: 24828666 [TBL] [Abstract][Full Text] [Related]
55. Advancing accuracy in breath testing for lung cancer: strategies for improving diagnostic precision in imbalanced data. Chen KC; Kuo SW; Shie RH; Yang HY Respir Res; 2024 Jan; 25(1):32. PubMed ID: 38225616 [TBL] [Abstract][Full Text] [Related]
56. Exhaled biomarkers in lung cancer. Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608 [TBL] [Abstract][Full Text] [Related]
57. Recognition of breathprints of lung cancer and chronic obstructive pulmonary disease using the Aeonose Krauss E; Haberer J; Barreto G; Degen M; Seeger W; Guenther A J Breath Res; 2020 Jul; 14(4):046004. PubMed ID: 32325432 [TBL] [Abstract][Full Text] [Related]
58. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer. Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460 [TBL] [Abstract][Full Text] [Related]
59. Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma. Yotsukura M; Yasuda H; Shigenobu T; Kaseda K; Masai K; Hayashi Y; Hishida T; Ohtsuka T; Naoki K; Soejima K; Betsuyaku T; Asamura H Lung Cancer; 2017 Jul; 109():45-51. PubMed ID: 28577949 [TBL] [Abstract][Full Text] [Related]
60. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer. Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]